Table 1.

Recommendations for use in pregnant and postpartum patients with COVID‐19, of medications administered routinely in pregnancy

Medication	Recommendation(s)
Antenatal corticosteroids for fetal lung maturation	Continue to administer when indicated for fetal lung maturation. There is insufficient evidence to strongly recommend use after 34 weeks of gestation. Risks and benefits should be weighed carefully in women with critical illness.
Magnesium sulfate	Since respiratory muscle weakness is a potential side effect of magnesium sulfate, it should be used judiciously in women with established respiratory distress.
NSAIDs	There are insufficient data available to recommend against use of low‐dose aspirin for prevention of placenta‐mediated complications. There are no COVID‐19‐specific contraindications to use of indomethacin as a tocolytic. There are no contraindications to use of NSAIDs for postpartum analgesia.

NSAIDs, non‐steroidal anti‐inflammatory drugs.